Literature DB >> 24880050

Vasodilatory effect of 14,15-epoxyeicosatrienoic acid on mesenteric arteries in hypertensive and aged rats.

Cui Yang1, Jinyan Yang2, Xiangting Xu3, Sanmei Yan2, Shitian Pan2, Xiaoxia Pan2, Changhong Zhang3, George Pakheng Leung4.   

Abstract

The objective of this study was to investigate the 14,15-epoxyeicosatrienoic acid (14,15-EET)-induced vasodilatations as well as the underlying signaling pathways in rat mesenteric arteries from young, adult and old normotensive (WKY) and hypertensive rats. Protein expressions for prostaglandin EP(1-4) receptors, large conductance Ca(2+)-activated K(+) (BK(Ca)) channels, and adenylate cyclase (AC) were determined together with 14,15-EET-induced vasodilatations in primary- versus secondary-branches of the mesenteric artery. Responses to 14,15-EET were greater in the smaller secondary- versus primary-branches (and also more sensitive with lower EC50) and were reduced in vessels from old (80 weeks) rats as well as from vessels from the spontaneous hypertensive rats (SHR). Regardless of age or hypertension responses to 14,15-EET were inhibited by the EP2 antagonist AH6809, BK(Ca) channel inhibitor iberiotoxin, or 3',5'-cyclic monophosphate (cAMP)-protein kinase A (PKA) pathway antagonists. These data indicate 14,15-EET-induced vasodilatation is mediated via the activation of EP2 receptors and opening of BK(Ca) channels. The expressions of the EP2 receptor and AC were markedly reduced in vessels from SHR as well as old rats, whereas BK(Ca) expression was reduced in old WKY and SHR, but not adult SHR. Furthermore, expression of the p53 protein, an indicator of cell senescence and apoptosis, was elevated in adult and old SHR as well as in old WKY. In summary, attenuated 14,15-EET-induced vasodilatation in mesenteric arteries from old normotensive WKY as well as adult and old SHR is associated with reduced expression of EP2 receptors and AC.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  14,15-Epoxyeicosatrienoic acid; Aging; Endothelium-derived hyperpolarizing factor; Hypertension; Mesenteric artery; Prostaglandin EP(2) receptor

Mesh:

Substances:

Year:  2014        PMID: 24880050     DOI: 10.1016/j.prostaglandins.2014.05.001

Source DB:  PubMed          Journal:  Prostaglandins Other Lipid Mediat        ISSN: 1098-8823            Impact factor:   3.072


  5 in total

1.  Functional screening for G protein-coupled receptor targets of 14,15-epoxyeicosatrienoic acid.

Authors:  Xuehong Liu; Zu-Yuan Qian; Fuchun Xie; Wei Fan; Jonathan W Nelson; Xiangshu Xiao; Sanjiv Kaul; Anthony P Barnes; Nabil J Alkayed
Journal:  Prostaglandins Other Lipid Mediat       Date:  2016-09-17       Impact factor: 3.072

Review 2.  Orally Active Epoxyeicosatrienoic Acid Analogs.

Authors:  William B Campbell; John D Imig; James M Schmitz; John R Falck
Journal:  J Cardiovasc Pharmacol       Date:  2017-10       Impact factor: 3.105

3.  GPR40 is a low-affinity epoxyeicosatrienoic acid receptor in vascular cells.

Authors:  Sang-Kyu Park; Anja Herrnreiter; Sandra L Pfister; Kathryn M Gauthier; Benjamin A Falck; John R Falck; William B Campbell
Journal:  J Biol Chem       Date:  2018-05-18       Impact factor: 5.157

4.  Identifying simultaneous matrix metalloproteinases/soluble epoxide hydrolase inhibitors.

Authors:  Ahmed A El-Sherbeni; Rabia Bhatti; Fadumo A Isse; Ayman O S El-Kadi
Journal:  Mol Cell Biochem       Date:  2022-01-24       Impact factor: 3.396

5.  Inhibition of Soluble Epoxide Hydrolase Attenuates Bosutinib-Induced Blood Pressure Elevation.

Authors:  Zhen Cui; Bochuan Li; Yanhong Zhang; Jinlong He; Xuelian Shi; Hui Wang; Yinjiao Zhao; Liu Yao; Ding Ai; Xu Zhang; Yi Zhu
Journal:  Hypertension       Date:  2021-10-04       Impact factor: 10.190

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.